SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001104659-23-119815
Filing Date
2023-11-20
Accepted
2023-11-20 12:09:56
Documents
1
Effectiveness Date
2023-11-20

Document Format Files

Seq Description Document Type Size
1 15-12G tm2329172d4_1512g.htm 15-12G 11171
  Complete submission text file 0001104659-23-119815.txt   12257
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-35668 | Film No.: 231421727
SIC: 2834 Pharmaceutical Preparations